ICYMI: PhRMA CMO Dr. Michael Ybarra speaks with Dr. Fabian Sandoval about clinical trial diversity
PhRMA
MAY 16, 2023
Enhancing clinical trial diversity is a challenge, but with a multi-faceted, community-centered approach, we can help underrepresented patients be more involved in the research and development of potential life-saving medical treatments.
Let's personalize your content